BioPortUSA

BioPortUSA News and Event Updates

06 Nov

BioPortUSA to present at Virtual Medica 2020

Medica represents the world's largest medical device show which takes place every November in Düsseldorf Germany. Due to the Coronavirus this event has had to go virtual in 2020. As a result, Zenit along with enterprise europe network have created a virtual brokerage and education platform which will allow thousands of participants to come together and benefit from one another. [...]

Read More
29 Oct

BioPortUSA helps Cerebriu with Pilot in the U.S.A.

#

Cerebriu, a Danish medical technology start-up focused on faster, personalized diagnostic imaging, engaged BioPort to help them identify a U.S. Radiology Department to conduct a pre-FDA pilot. We were fortunate enough to work with the leadership at SUNY Upstate to gain the interest of the Neuroradiology Department including Dr. Sylvie Destian. They have not only agreed to participate in a Retrospective Study pre-FDA but also be involved in a Prospective Clinical Trial to help achieve FDA approval.[...]

Read More
22 Sep

Medical Mountains: MedTalk

#

Demystifying market entry into the USA: What steps to take to successfully navigate the US healthcare market. More than ever, healthcare plays a critical role in the United States. But what does this mean for providers of medical technology products or solutions in Baden-Württemberg?[...]

Read More
28 May

BioPortUSA welcomes New Strategic Alliance Partner Map BioPharma

MAP BioPharma is a U.K. based life science consultancy that works with several partners who share their vision to accelerate patient access and support Pharmaceutical and MedTech companies in reaching patients sooner with their medicines, devices, and diagnostics. Christian Hill, CEO & Co-Founder of MAP BioPharma says that “BioPortUSA facilitates entry for overseas-life sciences companies into the United States so are a natural fit and addition to MAP’s network and we look forward to working with them to support our clients”. MAP BioPharm’s extensive knowledge of the European healthcare environment provides strategic guidance for successful European Market entry. Operating in a diverse market requires careful consideration. Their team will guide you through the necessary steps and provide a blueprint to ensure that you have covered all the requirements for the European Market. Christian has built a solid company, with an incredible network that will no doubt benefit our clients who are looking to go overseas. We in turn look forward to supporting MAPBioPharma clients who are looking to gain entry into the USA’’ says CEO & Founder Mark Lesselroth. [...]

Read More